You searched for "lesions"

1794 results found

Pilot trial of Fluoxetine for post-stroke homonymous hemianopia

The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...

Mid-term evaluation of the new Glaukos iStent

This is a prospective non-randomised interventional study to assess the efficacy and safety of the Glaukos GTS-400 iStent combined with cataract surgery. The patients enrolled in the study had cataract and primary open angle glaucoma, pseudoexfoliation glaucoma or ocular hypertension....

Paediatric spectacle dispensing: more than a frame and lenses

It’s incredibly rewarding to fit a child’s first pair of spectacles and see their face light up; looking around to see the wider world for the first time. Sometimes it is so obvious that even the most reluctant parent will...

Impact of COVID-19 on primary retinal detachments

This study aimed to describe the impact of the COVID-19 pandemic on the presentation characteristics, timings, and surgical decisions for primary rhegmatogenous retinal detachment (RRD). The cohort included all patients who presented to a Portuguese centre over a two-year period,...

Children and Young People’s Commissioner commends Sight Scotland for leading the way in inclusive education

Nicola Killean, Children and Young People’s Commissioner Scotland, has praised Sight Scotland for not only upholding the rights of visually impaired children and young people, but also empowering them to know their own rights so they can shape their own educational journey.

CHEC achieves Investors in People status

CHEC, one of the largest providers of community-based ophthalmology services in the UK, has achieved Investors in People status, with its company values and culture pinpointed as being fundamental to the company’s success.

Insights on medical AI for ophthalmology: an update on current perspectives

Artificial intelligence (AI) has immense promise for revolutionising medical practice. Generative AI is a form of AI in which algorithms are trained on datasets that can be used to generate new content, such as text, images or video based on...

NYU Langone Health performs world’s first whole-eye & partial-face transplant

Landmark whole-eye transplant is a major paradigm shift for potential vision therapies.

ESASO Course Series (Volume 2): Surgical Retina

This book comprises details of symposia / seminars on surgical aspects of retina presented by renowned authorities in ophthalmology from all over the world during ESASOS (European School for Advanced Studies in Ophthalmology) academic activities, which are mentioned in a...

BHVI Launches Myopia Awareness Week 2023

BHVI, an Australian not-for-profit organisation with an international focus on vision research, has announced today the launch of Myopia Awareness Week for 2023 – a global initiative relaunched in 2021, to bring attention to the growing epidemic of myopia in children across the world.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?

In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...